跳至主要内容
临床试验/NL-OMON46204
NL-OMON46204撤回4 期

SUBLIME study: patient controlled sublingual sufentanil tablets versus intravenous morphine to enhance the quality of recovery after laparoscopic donor nephrectomy. - SUBLIME study

Radboud Universitair Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
撤回
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Scheduled for living kidney donation
  • * Obtained informed consent
  • * Age *18 years

排除标准

  • * Inability to understand or follow instructions of use
  • * Contra-indications for patient controlled analgesia or opiates
  • * Chronic use of opiates
  • * Moderate to severe liver insufficiency (Child-Pugh score * 7)
  • * Severe renal insufficiency (eGFR <30ml/min/1,73 m2)
  • * Known or suspected allergy to morphine, sufentanil or one of the additives
  • * Signs of increased intracranial pressure, recent head injury or brain tumor.
  • * Biliary obstructive disorders or acute pancreatitis
  • * Bradyarrhythmia
  • * BMI > 35 kg/m2

研究者

相似试验